INTRODUCTION: Self-expanding metal stents (SEMS) are an established option for treating leaks in the upper gastrointestinal tract, and endoscopic vacuum therapy (EVT) has become a promising alternative. A novel approach is the use of an esophageal hybrid SEMS (VACStent®), which can maintain esophageal passage during EVT. We present the first study demonstrating successful use of the VACStent® for treating leaks of the upper gastrointestinal tract. METHOD: We performed a retrospective, single-center study of all patients who underwent endoscopic stenting with the VACStent® of leaks in the upper gastrointestinal tract. RESULTS: Indications for treatment with the VACStent® were: iatrogenic esophageal perforation (n = 1), spontaneous perforation (n = 2), esophageal fistula (n = 2), and anastomotic leak after upper gastrointestinal surgery (n = 5). Successful application of the VACStent® was achieved in all patients (n = 10; 100%) with a total of 15 interventions. VACStent® therapy was used as a first-line treatment in 5 patient (success rate 80%; 4 out 5 patients) and as a second-line treatment after failed previous endoscopic therapy in 5 patients (success rate 60%; 3 out of 5 patients). Overall, VACStent® treatment was successful in 70% of the patients (7 out of 10). No severe VACStent® treatment-related adverse events occurred. CONCLUSION: The initial experience has been that the technical application of the VACStent® is safe and technically feasible. However, due to the small number of patients this study could not show the clear advantages of this novel hybrid stent. More studies are necessary to show significant advantages.
INTRODUCTION: Self-expanding metal stents (SEMS) are an established option for treating leaks in the upper gastrointestinal tract, and endoscopic vacuum therapy (EVT) has become a promising alternative. A novel approach is the use of an esophageal hybrid SEMS (VACStent®), which can maintain esophageal passage during EVT. We present the first study demonstrating successful use of the VACStent® for treating leaks of the upper gastrointestinal tract. METHOD: We performed a retrospective, single-center study of all patients who underwent endoscopic stenting with the VACStent® of leaks in the upper gastrointestinal tract. RESULTS: Indications for treatment with the VACStent® were: iatrogenic esophageal perforation (n = 1), spontaneous perforation (n = 2), esophageal fistula (n = 2), and anastomotic leak after upper gastrointestinal surgery (n = 5). Successful application of the VACStent® was achieved in all patients (n = 10; 100%) with a total of 15 interventions. VACStent® therapy was used as a first-line treatment in 5 patient (success rate 80%; 4 out 5 patients) and as a second-line treatment after failed previous endoscopic therapy in 5 patients (success rate 60%; 3 out of 5 patients). Overall, VACStent® treatment was successful in 70% of the patients (7 out of 10). No severe VACStent® treatment-related adverse events occurred. CONCLUSION: The initial experience has been that the technical application of the VACStent® is safe and technically feasible. However, due to the small number of patients this study could not show the clear advantages of this novel hybrid stent. More studies are necessary to show significant advantages.
Authors: Bobby V M Dasari; David Neely; Andrew Kennedy; Gary Spence; Paul Rice; Eamon Mackle; Emmanuel Epanomeritakis Journal: Ann Surg Date: 2014-05 Impact factor: 12.969
Authors: Mike G Laukoetter; Rudolf Mennigen; Philipp A Neumann; Sameer Dhayat; Gabriele Horst; Daniel Palmes; Norbert Senninger; Thorsten Vowinkel Journal: Surg Endosc Date: 2016-10-05 Impact factor: 4.584
Authors: Pasquale Scognamiglio; Matthias Reeh; Karl Karstens; Eugen Bellon; Marcus Kantowski; Gerhard Schön; Antonia Zapf; Seung-Hun Chon; Jakob R Izbicki; Michael Tachezy Journal: Endoscopy Date: 2020-04-21 Impact factor: 10.093
Authors: Gregorios A Paspatis; Jean-Marc Dumonceau; Marc Barthet; Søren Meisner; Alessandro Repici; Brian P Saunders; Antonios Vezakis; Jean Michel Gonzalez; Stine Ydegaard Turino; Zacharias P Tsiamoulos; Paul Fockens; Cesare Hassan Journal: Endoscopy Date: 2014-07-21 Impact factor: 10.093
Authors: Marc Bludau; Hans F Fuchs; Till Herbold; Martin K H Maus; Hakan Alakus; Felix Popp; Jessica M Leers; Christiane J Bruns; Arnulf H Hölscher; Wolfgang Schröder; Seung-Hun Chon Journal: Surg Endosc Date: 2017-12-07 Impact factor: 4.584
Authors: Patrick Sven Plum; Till Herbold; Felix Berlth; Hildegard Christ; Hakan Alakus; Marc Bludau; De-Hua Chang; Christiane Josephine Bruns; Arnulf Heinrich Hölscher; Seung-Hun Chon Journal: World J Surg Date: 2019-03 Impact factor: 3.352